Aptagen, LLC
* The secondary structure may not be accurate because of MFOLD limitations on chemistries other than RNA/DNA.
hCD40L-human CD40 ligand (ID# 9938)
L-DNA
human CD40 ligand
Small Organic
2.55 nM (reported value)
74.7°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
Not provided
Secondary structure was predicted using DNA algorithm, which may not be accurate because the aptamer is comprised of LNA bases.
5'-LdALdALdALdALdALdGLdCLdALdGLdGLdTLdGLdTLdGLdALdALdALdALdGLdGLdALdCLdGLdTLdCLdALdALdALdCLdGLdALdCLdGLdTLdGLdALdCLdALdCLdA-3'
40
12438.2 g/mole
417500 L/(mole·cm)
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Lock, Protect, and Bind: In Vitro Selection of LNA-modified Aptamers Using a Mutant T7 RNA Polymerase Kevin Neis, Laia Civit, Kathrine Pedersen, Michael Schachtner, Jesper Wengel, Ralf Wagner, Steffen Thiel, Jørgen Kjems, Julián Valero bioRxiv 2025.04.09.647959; doi: https://doi.org/10.1101/2025.04.09.647959
Have your aptamer oligo synthesized
ORDER NOW



We are always looking for ways to improve. Please tell us what you think.